Natàlia Rodríguez

2.1k total citations
64 papers, 666 citations indexed

About

Natàlia Rodríguez is a scholar working on Molecular Biology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Natàlia Rodríguez has authored 64 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Psychiatry and Mental health and 13 papers in Clinical Psychology. Recurrent topics in Natàlia Rodríguez's work include Schizophrenia research and treatment (9 papers), Tryptophan and brain disorders (9 papers) and Obsessive-Compulsive Spectrum Disorders (8 papers). Natàlia Rodríguez is often cited by papers focused on Schizophrenia research and treatment (9 papers), Tryptophan and brain disorders (9 papers) and Obsessive-Compulsive Spectrum Disorders (8 papers). Natàlia Rodríguez collaborates with scholars based in Spain, United States and Puerto Rico. Natàlia Rodríguez's co-authors include Patricia Gassó, Sergi Mas, Amàlia Lafuente, Luisa Lázaro, Ana Blázquez, Ástrid Morer, María Teresa Plana, Susana García-Cerro, Yuanyuan Liang and Barbara J. Turner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Scientific Reports.

In The Last Decade

Natàlia Rodríguez

60 papers receiving 656 citations

Peers

Natàlia Rodríguez

PMH

PHARM

Yakup Albayrak Türkiye

Dirk Van West Belgium

Jaqueline Bohrer Schuch Brazil

Martina Balestri Italy

Yaira Z. Nuñez United States

Om Prakash Singh India

Chris D. Schubart Netherlands

Yukiko Kinoshita Japan

Trehani M. Fonseka Canada

Tetsuya Ando Japan

Yakup Albayrak Türkiye

Natàlia Rodríguez

119 ×0.7

169 ×1.3

PMH

91 ×0.8

50 ×0.5

PHARM

89 ×1.1

Citations per year, relative to Natàlia Rodríguez Natàlia Rodríguez (= 1×) peers Yakup Albayrak

Countries citing papers authored by Natàlia Rodríguez

Since Specialization

Citations

This map shows the geographic impact of Natàlia Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natàlia Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natàlia Rodríguez more than expected).

Fields of papers citing papers by Natàlia Rodríguez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natàlia Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natàlia Rodríguez. The network helps show where Natàlia Rodríguez may publish in the future.

Co-authorship network of co-authors of Natàlia Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Natàlia Rodríguez. A scholar is included among the top collaborators of Natàlia Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natàlia Rodríguez. Natàlia Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yassin, Walid, Carol A. Tamminga, Elisabetta C. del Re, et al.. (2025). Exposotypes in psychotic disorders. Scientific Reports. 15(1). 29003–29003.

Rodríguez, Natàlia, Aitor González, Gisela Mezquida, et al.. (2024). Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk. Psychiatry Research. 332. 115722–115722.

Mané, Anna, Natàlia Rodríguez, Gisela Mezquida, et al.. (2023). Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. Psychiatry Research. 325. 115249–115249. 2 indexed citations

Gassó, Patricia, Natàlia Rodríguez, Santiago Madero, et al.. (2023). Neurotoxic/Neuroprotective Effects of Clozapine and the Positive Allosteric Modulator of mGluR2 JNJ-46356479 in Human Neuroblastoma Cell Cultures. International Journal of Molecular Sciences. 24(3). 2054–2054. 3 indexed citations

Deutsch, Alana, Natàlia Rodríguez, Simon F. Roy, & Jonathan S. Leventhal. (2023). Treatment of persistent erythema multiforme with upadacitinib: A novel therapeutic approach. JAAD Case Reports. 34. 70–73. 4 indexed citations

Mezquida, Gisela, Patricia Gassó, Natàlia Rodríguez, et al.. (2022). Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. Psychological Medicine. 53(10). 4634–4647. 7 indexed citations

Gassó, Patricia, Mara Parellada, Pilar A. Sáiz, et al.. (2021). Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data. Frontiers in Pharmacology. 12. 729474–729474. 5 indexed citations

Gassó, Patricia, Joan Albert Arnáiz, Sergi Mas, et al.. (2020). Association study of candidate genes with obesity and metabolic traits in antipsychotic-treated patients with first-episode psychosis over a 2-year period. Journal of Psychopharmacology. 34(5). 514–523. 13 indexed citations

Rodríguez, Natàlia, David Rentero, Verónica Romero‐Ferreiro, & Lorena García‐Fernández. (2020). Impact of outbreak COVID-19 pandemic on psychiatry emergencies in Spain. Psychiatry Research. 295. 113581–113581. 23 indexed citations

10.

Rodríguez, Natàlia, Susana García-Cerro, Mara Parellada, et al.. (2020). Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms. Psychopharmacology. 237(7). 2151–2159. 4 indexed citations

11.

García-Cerro, Susana, Sergi Mas, Natàlia Rodríguez, et al.. (2020). The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice model. Journal of Psychiatric Research. 126. 8–18. 11 indexed citations

12.

García-Cerro, Susana, Sergi Mas, Carlos Sindreu, et al.. (2018). Different Modulation of Rps6 Phosphorylation by Risperidone in Striatal Cells Sub Populations: Involvement of the mTOR Pathway in Antipsychotic-Induced Extrapyramidal Symptoms in Mice. Neuropsychiatry. 8(3). 2 indexed citations

13.

Mas, Sergi, Natàlia Rodríguez, Ana E. Ortiz, et al.. (2018). Genetic Associations of Serotoninergic and GABAergic Genes in an Extended Collection of Early-Onset Obsessive-Compulsive Disorder Trios. Journal of Child and Adolescent Psychopharmacology. 29(2). 152–157. 8 indexed citations

14.

Plana, María Teresa, Natàlia Rodríguez, Patricia Gassó, et al.. (2018). Genetic variability in the serotoninergic system and age of onset in anorexia nervosa and obsessive-compulsive disorder. Psychiatry Research. 271. 554–558. 11 indexed citations

15.

Turner, Barbara J., Natàlia Rodríguez, Melissa A. Valerio, et al.. (2017). Less Exercise and More Drugs: How a Low-Income Population Manages Chronic Pain. Archives of Physical Medicine and Rehabilitation. 98(11). 2111–2117. 16 indexed citations

16.

Rodríguez, Natàlia, Ástrid Morer, Europa Azucena González‐Navarro, et al.. (2017). Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. Journal of Neuroinflammation. 14(1). 261–261. 54 indexed citations

17.

Mas, Sergi, Patricia Gassó, M. Torra, et al.. (2017). Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients. European Neuropsychopharmacology. 27(7). 647–656. 8 indexed citations

18.

Alejo-Cancho, Izaskun, Núria Torner, Igor Henrique Rodrigues Oliveira, et al.. (2016). Twenty-four cases of imported zika virus infections diagnosed by molecular methods. Diagnostic Microbiology and Infectious Disease. 86(2). 160–162. 4 indexed citations

19.

Cruz‐Correa, Marcia, Julyann Pérez‐Mayoral, María González‐Pons, et al.. (2015). Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome. Familial Cancer. 14(3). 415–425. 13 indexed citations

20.

Gassó, Patricia, Natàlia Rodríguez, Sergi Mas, et al.. (2014). Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients. The Pharmacogenomics Journal. 14(5). 457–462. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact